An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol
一项探索性开放标签多中心 I/II 期临床试验，旨在评估产后或产前产后联合应用同种异体扩增胎儿间充质干细胞治疗婴幼儿及胎儿重度成骨不全症的安全性和有效性：BOOSTB4 试验方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-079767
Sagar, Rachel L; Åström, Eva; Chitty, Lyn S; Crowe, Belinda; David, Anna L; DeVile, Catherine; Forsmark, Annabelle; Franzen, Vera; Hermeren, Göran; Hill, Melissa; Johansson, Mats; Lindemans, Caroline; Lindgren, Peter; Nijhuis, Wouter; Oepkes, Dick; Rehberg, Mirko; Sahlin, Nils-Eric; Sakkers, Ralph; Semler, O; Sundin, Mikael; Walther-Jallow, Lilian; Verweij, E J T Joanne; Westgren, Magnus; Götherström, Cecilia
